Silicon-chip-based DNA synthesis technology
| Date | Round | Amount |
|---|---|---|
| Feb 2023 | Series B UK synthetic-biology company Evonetix raised a $24m Series B extension led by Foresite Capital (with Molten Ventures), bringing the round to $54m. | $24M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.